🏢 官网IRSYKCodex · 实盘不做把握 9/10
北京时间·🕒 发布 21:34:00(美东 09:34)·⟳ 抓取 21:36:45·⚡ 决策 08-05 21:38:30 +1m45s·82.9 天前
Stryker宣布季度股息维持每股0.88美元
Stryker本次公告为例行季度分红，每股0.88美元较上一季度不变，仅同比增加4.8%，没有新增订单、盈利指引或资本回报超预期信息。
📄 原文SYK↗ 原文
Stryker declares an $0.88 per share quarterly dividend
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has decla…
不做 Stryker（SYK.US）
例行分红公告且股息较上一季度不变，登记日和派息日已过，无法形成可交易的新催化，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-05 · 扩散 low · price-in 风险 high ↗
关键理由
- Stryker本次公告为例行季度分红，每股0.88美元较上一季度不变，仅同比增加4.8%，没有新增订单、盈利指引或资本回报超预期信息。
主要风险
- 公告披露的股权登记日和派息日均早于公告日，作为交易催化的时效性和可执行性均不足。
原文全文
展开原文 · 1,047 字
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com
For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com
Source: Stryker Corporation
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com
For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com
Source: Stryker Corporation
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。